HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Canada Tilts At Unneeded Fixes In Self-Care Product Regulation Overhaul – Industry

This article was originally published in The Rose Sheet

Executive Summary

Health Canada says its planned overhaul will not scrap the current natural health product framework, but industry is skeptical. In a Council for Responsible Nutrition webinar, an industry consultant says marketers of OTC drugs, supplements and cosmetics are discussing the proposal's negative implications with the agency.

You may also be interested in...

New Plain Language Labeling Rules Come Into Play For Non-Rx Drugs In Canada

Sponsors of non-prescription drugs in Canada have until June 2021 to comply with new labeling obligations aimed at making it easier for patients and healthcare professionals to understand important information about the safe use of medicines.

Hatch Question, Gottlieb Response Speak Volumes About DSHEA Reliance

Gottlieb is not the first FDA commissioner nominee to profess support for its regulatory framework established by DSHEA, but the focus of Hatch's question serves stronger notice than similar questions asked of previous candidates that the agency authority to enforce in the space does need adjustment.

Canada Proposes Tiered Risk Framework For Regulating Self-Care Items

Marketers of traditional medicines and homeopathic products could have a harder time using health claims under Health Canada’s proposal for regulating “self-care” products. At the same time, the revised framework would grease the path to market for some dietary supplements and OTC drugs, while cosmetics requirements would be largely unaffected.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts